| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 24.752 | 60.144 | 71.081 | 105.707 | 103.545 | 205.855 |
| Total Income - EUR | - | - | - | - | 25.597 | 61.514 | 71.783 | 124.858 | 103.587 | 206.974 |
| Total Expenses - EUR | - | - | - | - | 24.477 | 65.331 | 77.153 | 123.355 | 116.986 | 175.641 |
| Gross Profit/Loss - EUR | - | - | - | - | 1.120 | -3.817 | -5.370 | 1.503 | -13.399 | 31.334 |
| Net Profit/Loss - EUR | - | - | - | - | 353 | -4.382 | -6.088 | 264 | -13.399 | 30.031 |
| Employees | - | - | - | - | 0 | 0 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Revobio S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 82 | 80 | 592 | 348 | 102 | 0 |
| Current Assets | - | - | - | - | 12.573 | 18.321 | 23.088 | 38.334 | 62.412 | 106.670 |
| Inventories | - | - | - | - | 9.620 | 16.106 | 19.135 | 22.901 | 23.388 | 25.630 |
| Receivables | - | - | - | - | 1.513 | 76 | 2.492 | 8.436 | 22.109 | 65.507 |
| Cash | - | - | - | - | 1.439 | 2.139 | 1.462 | 6.996 | 16.915 | 15.533 |
| Shareholders Funds | - | - | - | - | 395 | -4.110 | -10.123 | -9.939 | -23.307 | 6.854 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 12.259 | 22.512 | 33.804 | 48.620 | 85.821 | 99.816 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4791 - 4791" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Revobio S.r.l.